Access the AMCP Legislative Days 2024 Education Slides, to learn the terminology most associated with a Member of Congress and understand key advocacy vocabulary to help explain AMCP’s positions on the the Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) and the Medicaid VBPs for Patients (MVP) Act (H.R. 2666).
The impact of value assessment frameworks on formulary decision-making continues to create debate and influence manufacturers’ evidence-gathering strategies. Join our expert panel as they explore the evolving landscape of these frameworks, uncover payer perspectives, discuss questions and considerations regarding the real-world application, and forecast emerging trends that will shape value assessment in the future.
Value-based contracts often require significant time to reach final negotiation and implementation. Disconnect, misalignment, and lack of a common framework for value-based purchasing agreements has exacerbated these challenges. This slide deck provides a unified language for discussing and designing value-based contracts across payers, provider systems, and manufacturers.